Antimalarial potential of Moringa oleifera Lam. (Moringaceae): A review of the ethnomedicinal, pharmacological, toxicological, and phytochemical evidence

Abstract

Several regions of the world frequently use the species Moringa oleifera Lam. (Moringaceae) in traditional medicine. This situation is even more common in African countries. Many literature reports point to the antimalarial potential of this species, indicating the efficacy of its chemical compounds against malaria-causing parasites of the genus Plasmodium. From this perspective, the present study reviews the ethnobotanical, pharmacological, toxicological, and phytochemical (flavonoids) evidence of M. oleifera, focusing on the treatment of malaria. Scientific articles were retrieved from Google Scholar, PubMed^®, ScienceDirect^®, and SciELO databases. Only articles published between 2002 and 2022 were selected. After applying the inclusion and exclusion criteria, this review used a total of 72 articles. These documents mention a large use of M. oleifera for the treatment of malaria in African and Asian countries. The leaves (63%) of this plant are the main parts used in the preparation of herbal medicines. The in vivo antimalarial activity of M. oleifera was confirmed through several studies using polar and nonpolar extracts, fractions obtained from the extracts, infusion, pellets, and oils obtained from this plant and tested in rodents infected by the following parasites of the genus Plasmodium: P. berghei, P. falciparum, P. yoelii, and P. chabaudi. Extracts obtained from M. oleifera showed no toxicity in preclinical tests. A total of 46 flavonoids were identified in the leaves and seeds of M. oleifera by different chromatography and mass spectrometry methods. Despite the scarcity of research on the antimalarial potential of compounds isolated from M. oleifera, the positive effects against malaria-causing parasites in previous studies are likely to correlate with the flavonoids that occur in this species.

Keywords:
Malaria; Medicinal plants; Flavonoids; Plasmodium; Antiplasmodial

Background

Human malaria is an infectious disease caused by five species of Plasmodium ( Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium knowlesi, and Plasmodium malariae) [1]. Its transmission between humans occurs through the bite of female Anopheles mosquitoes infected with Plasmodium spp. [2]. Among the species of parasites that infect humans, Plasmodium falciparum is the main cause of the severe form of the disease, which can lead to death and is responsible for 99.7% of infections in sub-Saharan Africa [3]. Malaria symptoms usually include high fever, headache, muscle aches, vomiting, chills, and fatigue [4]. Despite major advances in the control of this disease, estimates for 2021 suggest a total of about 247 million clinical cases and 619,000 deaths from malaria worldwide [5].

Despite the modest reduction in the number of cases over the past 20 years, malaria remains a global health problem [6], even with the production of the Mosquirix^TM vaccine, which is not yet widely available [7]. Increasing resistance to drugs currently used in the treatment of this disease is also a serious threat to global malaria control efforts [8]. In this way, the discovery of antimalarial drugs is driven by the need to obtain new therapeutic alternatives to treat infections and save lives in a context of a constantly evolving drug resistance [9]. Herbal medicine has been considered the backbone of malaria treatment for thousands of years. The first antimalarial drug (quinine) was isolated from the bark of a tree of the family Rubiaceae belonging to the genus Cinchona [10].

Medicinal plants are viable alternatives for the isolation and screening of active phytochemicals that may be responsible for antiplasmodial activity in in vitro and in vivo assays [11]. In in vivo tests, rodents are infected with four different species of Plasmodium (P. berghei, P. chabaudi, P. yoelii, and P. vinckei) and used in research aimed at discovering new antimalarial drugs [12]. Flavonoids apigenin, kaempferol, rutin, and quercetin occur in several plant species and showed promising antimalarial activity in in vitro and in vivo experiments [13- 18]. In addition, the flavonoids are phytoconstituents with the ability to scavenge free radicals and act as antioxidants [19]. These properties make flavonoids very promising for antimalarial activity, as during malaria infections both the host and the parasites are under severe oxidative stress [20]. In summary, the infected host presents an exacerbated production of free radicals. These free radicals produced in large quantities cause damage to the vascular endothelium, increasing vascular permeability and platelet adhesion, known to be associated with severe cerebral malaria [21, 22]. In this context, flavonoids are promising antioxidants to reverse this clinical condition, deserving a highlight compared to other phytochemicals in the treatment of malaria.

Moringa, the single genus in the family Moringaceae, is one of the most phenotypically varied groups of angiosperms [23, 24]. With only 13 species, Moringa occurs in arid regions of Africa, Madagascar, the Arabian Peninsula, and India [23, 25]. The Moringagenus has high antioxidant activity mainly due to its high content of flavonoids. Most of the flavonoids present in the genus are in the flavanol and glycoside form [26]. Moringa oleifera Lam., popularly known as drumstick and horseradish tree, is native to sub-Himalayan areas of the Indian subcontinent and has been introduced in many tropical countries [25, 27, 28]. Researchers attribute the medicinal, nutritional, and industrial properties of this plant to the constituents that occur in its roots, bark, leaves, flowers, fruits, and seeds [29, 30].

Ethnobotanical and ethnopharmacological surveys carried out in African and Asian countries have reported the use of M. oleifera for the treatment of malaria in traditional communities [31- 38]. These ethnomedicinal uses have been confirmed through in vivo and in vitro assays using different products obtained from the leaves and seeds of M. oleifera against several malaria-causing species of Plasmodium [39- 44]. It is important to emphasize that the phytochemicals isolated from this species have not yet had their antimalarial activity evaluated in scientific research.

Considering that malaria still causes several deaths around the world [5] and that the discovery of new antimalarial drugs is of great importance in assisting in the treatment of infections caused by parasites of the genus Plasmodium [9], the present study reviews the ethnobotanical, pharmacological, toxicological, and phytochemical (flavonoids) evidence of M. oleifera, focusing on the treatment of malaria.

Methods

Database search

Scientific articles were retrieved from Google Scholar (https://scholar.google.com.br/), PubMed^® (https://pubmed.ncbi.nlm.nih.gov/), ScienceDirect^® (https://www.sciencedirect.com/search), and SciELO (https://search.scielo.org/) databases. The keywords used in the searches were: “ Moringa oleifera AND ethnobotany AND malaria”, “ Moringa oleifera AND medicinal use AND malaria”, “ Moringa oleifera AND antimalarial”, “ Moringa oleifera AND antiplasmodial”, “ Moringa oleifera AND Plasmodium AND malaria”, “ Moringa oleifera AND toxicity”, “ Moringa oleifera AND phytochemistry”, and “ Moringa oleifera AND flavonoids”.

Inclusion and exclusion criteria

Only scientific articles published between 2002 and 2022 addressing the following information about M. oleifera were selected: 1) Ethnomedicinal uses of M. oleifera by traditional communities in different regions of the world; 2) In vitro and in vivo antimalarial activity of extracts, fractions, oils, and other products obtained from M. oleifera; 3) Toxicity and biological safety of products obtained from this plant; 4) Flavonoids isolated and identified in M. oleifera that have already been reported in the literature. As for the exclusion criteria, review articles, e-books, book chapters, undergraduate theses, Masters’ theses, Ph.D. theses, and works published in technical or scientific events were excluded.

Data screening and categorization of information

A total of 130 scientific articles were selected from the databases (Figure 1). Subsequently, 58 documents that did not meet the criteria of this review were excluded. Finally, the present study considered 72 articles containing data on ethnomedicinal uses, pharmacological activities, and toxicological and phytochemical (flavonoids) investigations of M. oleifera focusing on the treatment of malaria (Figure 1, ^{Additional file 1}). The results were grouped in tables and represented in graphs when necessary. The general information described in the “Results” section has been categorized by: “Botanical aspects of Moringa oleifera”, “Ethnomedicinal uses of Moringa oleifera for the treatment of malaria”, “ In vivo and in vitro antimalarial activity of Moringa oleifera”, “Toxicity of Moringa oleifera”, and “Flavonoids identified in Moringa oleifera”.

Figure 1.
Flow diagram of selection of scientific documents included in this review

Results

Botanical aspects of Moringa oleifera

Moringa oleifera is native to northwest India and adapted to arid and semiarid environments. This plant has gained popularity in certain developing countries due to its medicinal, industrial, and nutritional properties [29]. African, South American, Central American, and Asian countries currently cultivate M. oleifera commercially (Figure 2) [45]. This is a medium-sized, fast-growing evergreen tree about 10 to 12 m tall. The bark of mature trees is gray-white while young shoots have a purplish or greenish-white bark [27]. It has a more conventional trunk and fibrous and resistant roots [46]. The fruits are long, woody pods, which when ripe open into three valves, containing trivalve seeds with longitudinal wings. Its pinnate leaves are divided into leaflets arranged on a rachis. The flowers are zygomorphic with five petals, five sepals, five functional stamens, and several staminodes. In addition, the flowers have pedicels and axillary inflorescences [ 47].

Figure 2.
Geographic distribution of Moringa oleifera. Map prepared by Bezerra, J.J.L. in MapChart©

Ethnomedicinal uses of Moringa oleifera for the treatment of malaria

The following African countries use Moringa oleifera as a traditional medicine for the treatment of malaria: Nigeria, Uganda, Benin, Ghana, Togo, Tanzania, Cameroon, Kenya, Ethiopia, Mozambique, and Cote d’Ivoire. Regarding Asia, ethnobotanical and ethnopharmacological studies have reported the use of this plant for the treatment of malaria in Indonesia, India, and Pakistan (Figure 3). The fact that medicinal indications of M. oleifera occur mainly in African countries may correlate directly with the high incidence of cases of this disease in sub-Saharan Africa. In recent years, researchers have carried out several studies on the impact, progression, and control of malaria in this region [48- 50].

Figure 3.
Ethnomedicinal uses of Moringa oleifera for the treatment of malaria in African and Asian countries. Map prepared by Bezerra, J.J.L. in MapChart^©.

Traditional communities mainly use M. oleifera leaves (63%) for the treatment of malaria. The other most used parts are seeds (13%), roots (9%), flowers (5%), and stems (4%) (Figure 4 and Figure 5). These plant parts are used for the preparation of decoction, maceration, infusion, paste, and cataplasm. Table 1 shows further information on the forms of administration of herbal medicines. The literature often reports a wide use of plant leaves for the treatment of malaria, confirming the findings of this study [51- 53].

Table 1.
Plant organ, preparation mode and ethnomedicinal uses of Moringa oleifera for the treatment of malaria.

Plant organ	Preparation mode	Form of administration	Countries	References
Leaves	Maceration, decoction	Oral use	Benin	[ 31]
Leaves	Infusion	1 glass decoction of leaves thrice a day	Pakistan	[ 32]
Leaves	-	-	Ethiopia	[ 33]
Leaves, seed, stem bark	Decoction	-	Nigeria	[ 34]
Root	Paste, cataplasm	-	Indonesia	[ 35]
Leaves	In natura	Chew the leaves seven times a day	Uganda	[ 36]
Leaves, bark	Decoction, maceration	-	Nigeria	[ 37]
Bark	-	-	India	[ 38]
Leaves	Boil in water as infusion	Drink the extract	Nigeria	[ 54]
Leaves	Decoction	Oral use, bath	Nigeria	[ 55]
Leaves	-	-	Nigeria	[ 56]
Leaves	Decoction, maceration	-	Nigeria	[ 57]
Leaves	-	-	Nigeria	[ 58]
Leaves	Decoction, maceration	-	Nigeria	[ 59]
Leaves	Decoction	Boil leaves for 20 minutes and consume half cup morning and evening	Nigeria	[ 60]
Leaves	Ground leaves + little water	Drink regularly 3 small glasses/day until you are healed	Nigeria	[ 61]
Leaves	-	-	Uganda	[ 62]
Leaves	Decoction	-	Uganda	[ 63]
Leaves	Decoction, maceration	Oral use	Benin	[ 64]
Leaves	Ground leaves + little water	Drink regularly 3 small glasses/day until well	Benin	[ 65]
Leaves	Aqueous boiling	-	Ghana	[ 66]
Leaves	Decoction	Boil and drink one cupful of decoction thrice daily for 3-5 days or mash leaves in water and drink thrice daily	Ghana	[ 67]
Leaves, seed	Leaves boiled in strained corn ( Zea mays L.) dough liquid	-	Ghana	[ 68]
Leaves	Maceration	Body bath	Togo	[ 95]
Leaves	-	-	Benin	[ 96]
Leaves, flower	Maceration	One spoon twice daily	Nigeria	[ 97]
Leaves	Decoction. Dry powder used to make warm infusion	-	Tanzania	[ 98]
Leaves, root	Decoction. Boil handful of fresh leaves in a cup of water.	Drink one glass 3 times a day for adults. For children, give 1 tsp 3 times a day. Roots chewed raw or boiled and drunk 2 times a day. Pick and chew handful of fresh leaves 2-3 times a day for 3-4 days	Uganda	[ 99]
Leaves, seed	-	-	Cameroon	[ 100]
Flower, leaves, seed, root	Infusion	Chewed, boiled and infusion taken orally	Kenya	[ 101]
Leaves, seed	Cold maceration	-	Nigeria	[ 102]
Fruit	-	-	Togo	[ 103]
Leaves, flower	Decoction	Drinking, eating	Nigeria	[ 104]
Leaves, roots	Decoction	Chewed raw	Uganda	[ 105]
Leaves, seed, whole plant	Decoction, infusion	-	Nigeria	[ 106]
Root, stem, leaves	-	-	Mozambique	[ 107]
Leaves, seed	-	-	Nigeria	[ 108]
Leaves	Decoction, infusion	Oral use	Cote d’Ivoire	[ 109]

Ethnobotanical and ethnopharmacological surveys carried out in Nigeria have highlighted the constant use of M. oleifera leaves for the treatment of malaria by traditional communities in the country [54- 61]. Other African countries that also stood out in the use of M. oleifera leaves were Uganda [36, 62, 63], Benin [31, 64, 65], and Ghana [66- 68]. Scientific research shows that extracts from the leaves of this plant had in vivo antimalarial activity [69- 72], confirming its use in traditional medicine.

Figure 4.
Organs of Moringa oleifera used for the treatment of malaria.

Figure 5.
Main organs of Moringa oleifera used for the treatment of malaria: (A) Leaves, (B) Flowers, (C) Ripe and unripe fruits, (D) Seeds. Photos by: Bezerra, J.J.L.

In vivo and in vitro antimalarial activity of Moringa oleifera

Several studies have reported the in vivo and in vitro antimalarial activity of M. oleifera (Table 2). Researchers mostly used in vivo methods to evaluate the potential of polar and nonpolar extracts, fractions obtained from extracts, infusions, pellets, and oils obtained from this plant and tested in rodents infected by the following parasites of the genus Plasmodium: P. berghei, P. falciparum, P. yoelii, and P. chabaudi. Leaves were the most used parts to obtain the evaluated products. Regarding in vitro tests, only two studies reported the potential of M. oleifera against the parasite P. falciparum. This parasite infects humans and causes the most severe form of malaria [40, 73].

Table 2.
Plant organ and phytoproducts concentration of phytoproducts Moringa oleifera for i n vivo and in vitro antimalarial activity.

Plant organ	Product	Concentration or dose	Strain	Method	References
Leaves	Acetone extract	200, 400 and 600 mg/kg	Plasmodium berghei	In vivo	[ 39]
Leaves	Hexane extract, methanol extract, aqueous extract	6.25, 12.5, 25 and 50 µg/mL	Plasmodium falciparum (3D7)	In vitro	[ 40]
Leaves	Aqueous extract, ethanol extract	100, 200, 400 and 800 mg/kg	Plasmodium berghei	In vivo	[ 41]
Seed	Ethanol extract	200, 300 and 500 mg/kg	Plasmodium berghei	In vivo	[ 42]
Leaves	Pellets	30 and 60 mg/mouse	Plasmodium chabaudi	In vivo	[ 43]
Seed	Oil	200, 400 and 800 mg/kg	Plasmodium berghei (NK65)	In vivo	[ 44]
Leaves	Aqueous extract	250, 500, 750 and 1000 mg/kg	Plasmodium berghei (NK65)	In vivo	[ 69]
Leaves	Aqueous extract	100, 500 and 1000 mg/kg	Plasmodium berghei (ANKA)	In vivo	[ 70]
Leaves	Aqueous extract	500, 1000 and 2000 mg/kg	Plasmodium berghei (ANKA)	In vivo	[ 71]
Leaves	Aqueous extract	100, 500 and 1000 mg/kg	Plasmodium berghei (ANKA)	In vivo	[ 72]
Flowers, leaves, stems	Lipophilic extract, methanol extract	6 and 25 µg/mL	Plasmodium falciparum	In vitro	[ 73]
Leaves	Methanol extract and its fractions	50 and 100 mg/kg	Plasmodium berghei (NK65)	In vivo	[ 74]
Leaves	Aqueous extract	100, 1000 and 2000 mg/kg	Plasmodium berghei (ANKA)	In vivo	[ 75]
Leaves	n-Hexane extract, ethanol extract	50, 100 and 200 mg/kg	Plasmodium berghei	In vivo	[ 76]
Flowers, leaves	Methanol extract	125, 250, 500 and 1000 mg/kg	Plasmodium yoelii (N-67)	In vivo	[ 77]
Seed	n-Hexane extract, ethanol extract	50, 100 and 200 mL/kg	Plasmodium berghei	In vivo	[ 110]
Leaves	Bioactive fraction	100, 150 and 200 mg/kg	Plasmodium berghei Q (N1923)	In vivo	[ 111]
Leaves	Aqueous extract	150 mg/kg	Plasmodium yoelii	In vivo	[ 112]
Leaves	Infusion	100, 200 and 400 mg/kg	Plasmodium berghei (ANKA)	In vivo	[ 113]

According to Orman et al. [69], the parasitic suppression of the aqueous extract of M. oleifera leaves was not entirely dose-dependent in mice. This is because the two lowest doses, 250 mg/kg (69.31% of suppression) and 500 mg/kg (77.26% of suppression), exhibited better suppression of P. berghei (NK65) than the two highest doses, 750 mg/kg (25.28% of suppression) and 1000 mg/kg (7.12% of suppression). In turn, Ogundapo et al. [74] observed in their in vivo antimalarial studies that the methanolic extract of M. oleifera leaves (50 and 100 mg/kg) was able to suppress 42.37 and 55.30 %, respectively, the parasitemia induced by P. berghei. Somsak et al. [71] reported that the aqueous extract of M. oleifera leaves at doses of 500, 1000, and 2000 mg/kg showed antimalarial activity of 35, 40, and 50%, respectively, against P. berghei.

Dondee et al. [70] observed that the aqueous extract of M. oleifera leaves significantly inhibited parasitemia in mice infected with P. berghei in a dose-dependent manner. Percent inhibitions of 42.86, 71.43, and 85.71% occurred at doses of 100, 500, and 1000 mg/kg of the extract, respectively. Dondee et al. [75] also reported results similar to these, but evaluated doses 100, 1000, and 2000 mg/kg. Despite the concentration-dependent behavior, it can be inferred that due to the low variation between the doses of 1000 and 2000 mg/kg, in the suppression of the parasitemia it is already close to a maximum concentration tending to a constant. At the dose of 200 mg/kg, ethanolic and n-hexane extracts from M. oleifera leaves revealed 98.3 and 100% (suppression) of total parasitemia in mice infected with P. berghei, respectively [76]. Mulisa et al. [39] reported that the acetone extract from M. oleifera leaves at doses of 200, 400, and 600 mg/kg suppressed P. berghei parasitemia by 31.1, 55.9, and 77.0%, respectively.

The dose of 800 mg/kg of aqueous and ethanolic extracts of M. oleifera leaves suppressed P. berghei infection in mice by 99.48 and 97.75%, respectively [41]. According to Obediah and Obi [42], doses of 200 mg/kg (68.93% of suppression), 300 mg/kg (72.56% of suppression), and 500 mg/kg (67.01% of suppression) of the ethanol extract of M. oleifera seeds showed good chemosuppression of P. berghei multiplication in relation to the negative control. According to Shrivastava et al. [77], extracts of M. oleifera flowers and leaves showed dose-dependent suppression in mice infected with the parasite P. yoelii (N-67). At the lowest dose (125 mg/kg), the flower and leaf extracts suppressed infection by 40.74 and 31.85 %, respectively, after four days of experiment [77].

In an in vitro experiment, Daskum et al. [40] tested different extracts of M. oleifera leaves against the P. falciparum strain 3D7. According to these authors, although some extracts were more potent than others, all were biologically active with the following IC₅₀ values: hexane extract IC₅₀ = 3.36 µg/mL; methanolic extract IC₅₀ = 3.44 µg/mL; aqueous extract IC₅₀ = 4.09 µg/mL. It is important to highlight that the most severe form of malaria and the mortality rate in humans often correlate with infections caused by P. falciparum [78- 80]. Thus, studies focusing on the evaluation of new drugs against this specific parasite are of great importance for public health.

Toxicity of Moringa oleifera

Researchers evaluated the toxicity of different products obtained from M. oleifera in experimental rodent models [ 39, 42, 70, 71, 75, 77]. These studies regarded the extracts obtained from this species as biologically safe since the evaluated animals did not present relevant behavioral or physiological changes during the acute and subacute toxicity experiments. However, despite the extracts being considered safe, a recent study by Abdulahi et al. [44] reported that precautions should be taken when administering M. oleifera seed oil at a dose greater than 200 mg/kg, as this product may be mildly toxic.

According to Somsak et al. [71], the aqueous extract of M. oleifera leaves orally administered in a single dose of up to 4000 mg/kg showed no visible signs of toxicity (paw licking, salivation, stretching, urination, lacrimation, hair erection, and reduction in feeding activity) in mice. Additionally, no mortality occurred within the observation period of 30 days. Dondee et al. [70] observed similar results, reporting that the aqueous extract of M. oleifera leaves administered orally at a dose of up to 4000 mg/kg also did not cause mortality in mice over the seven days of observation. When orally administering the single dose of 2000 mg/kg of the aqueous extract of M. oleifera leaves to mice, Dondee et al. [75] reported the absence of lethal effect in the animals up to one week after the experiment. However, at the dose of 4000 mg/kg, these authors observed tremors and drowsy activities after 24 hours of extract administration.

In a study carried out by Mulisa et al. [39], the acetone extract of M. oleifera leaves did not result in animal death at the dose of 2000 mg/kg. This implies that the lethal dose (LD₅₀) of the extract was greater than 2000 mg/kg. Moreover, Obediah and Obi [42] reported that the ethanol extract of M. oleifera seeds was not considered toxic at the highest dose of 911 mg/kg administered to albino rats. According to Shrivastava et al. [77], the results of the subacute toxicity evaluation indicated that both methanolic extracts (flower and leaves) were not considered toxic to mice, even at the highest dose level (3000 mg/kg), in the first 24 h, as well as in the following 14 days of the experiment.

Flavonoids identified in Moringa oleifera

By using different chromatography and mass spectrometry methods, researchers identified a total of 46 flavonoids in M. oleifera leaves and seeds (Table 3). Some examples of these flavonoids are apigenin [81, 82], kaempferol [81, 82], rutin [ 83, 84], and quercetin [84- 85] (Figure 6). To date, however, the literature does not mention the antimalarial potential of phytochemicals isolated from this plant. Several other studies have reported the promising antimalarial potential of apigenin, kaempferol, rutin, and quercetin in in vitro and in vivo experiments [13- 18]. The antimalarial activity of M. oleifera may thus correlate directly with these flavonoids. Flavonoids are usually well known to show effects against malaria-causing parasites [86- 89].

Table 3
Plant organ, identification methods, and flavonoids present in Moringa oleifera.

Compound	Plant organ	Identification method	References
1) Quercetin	Seed, leaves	HPLC, UHPLC-ESI-QTOF-MS/MS, NMR, ESIMS, HPLC-Q-TOF-MS/MS, HPLC-DAD, LC-MS	[ 81, 82, 84, 114- 118]
2) Epicatechin	Seed, leaves	HPLC, LC-MS	[ 82, 114]
3) Catechin	Seed, Leaves	HPLC	[ 85, 114]
4) Isoquercetin	Leaves	HPLC	[ 119]
5) Kaempferol acetyl dihexose	Leaves	UHPLC-qTOF-MS	[ 120]
6) Quercetin acetyl dihexose	Leaves	UHPLC-qTOF-MS	[ 120]
7) Quercetin hexose	Leaves	UHPLC-qTOF-MS	[ 120]
8) Quercetin hydroxy-methylglutaroyl hexose	Leaves	UHPLC-qTOF-MS, UHPLC-ESI-QTOF-MS/MS	[ 116, 120]
9) Quercetin acetyl hexose	Leaves	UHPLC-qTOF-MS	[ 120]
10) Kaempferol hexose	Leaves	UHPLC-qTOF-MS	[ 120]
11) Isorhamnetin hexose	Leaves	UHPLC-qTOF-MS	[ 120]
12) Quercetin malonyl hexose	Leaves	UHPLC-qTOF-MS	[ 120]
13) Kaempferol hydroxy-methylglutaroyl hexose	Leaves	UHPLC-qTOF-MS	[ 120]
14) Kaempferol acetyl hexose	Leaves	UHPLC-qTOF-MS	[ 120]
15) Kaempferol malonyl hexose	Leaves	UHPLC-qTOF-MS	[ 120]
16) Isorhamnetin hydroxy-methylglutaroyl hexose	Leaves	UHPLC-qTOF-MS	[ 120]
17) Isorhamnetin acetyl hexose	Leaves	UHPLC-qTOF-MS	[ 120]
18) Luteolin-6-C-glucoside	Seed	LC-MS	[ 121]
19) Hesperidin	Seed	LC-MS	[ 121]
20) Kaempferol	Leaves	UHPLC-ESI-QTOF-MS/MS, NMR, ESIMS, HPLC-Q-TOF-MS/MS, HPLC-DAD, LC-MS	[ 81, 82, 84, 115- 118]
21) Myricetin	Leaves	HPLC	[ 115]
22) Rutin	Leaves	HPLC-ESI-MS, HPLC-Q-TOF-MS/MS, LC-MS, HPLC-DAD, UHPLC-Q-Exactive-MS/MS	[ 81- 85, 122, 123]
23) Vitexin	Leaves	UHPLC-ESI-QTOF-MS/MS, UHPLC-Q-Exactive-MS/MS	[ 116, 123]
24) Astragalin	Leaves	UHPLC-ESI-QTOF-MS/MS, UHPLC-Q-Exactive-MS/MS	[ 116, 123]
25) Quercetin-3-glucoside	Leaves	HPLC-ESI-MS, HPLC-DAD	[ 83, 122]
26) Kaempferol-3- O-glucoside	Leaves	HPLC-ESI-MS, HPLC-DAD	[ 83, 122]
27) Quercetin-3-acetyl-glucoside	Leaves	HPLC-ESI-MS, UHPLC-ESI-QTOF-MS/MS, HPLC-DAD	[ 83, 116, 122]
28) Quercetin 3- β-D-glucoside	Leaves	UHPLC-ESI-QTOF-MS/MS	[ 116]
29) Isovitexin	Leaves	UHPLC-ESI-QTOF-MS/MS	[ 116]
30) Kaempferol-3- O-rutinoside	Leaves	HPLC-Q-TOF-MS/MS, HPLC-DAD	[ 81, 84]
31) Quercetin 3- O-galactoside	Leaves	HPLC-DAD	[ 118]
32) Quercetin 3- O-rhamnoside	Leaves	HPLC-DAD	[ 118]
33) Kaempferol 3- O-galactoside	Leaves	HPLC-DAD	[ 118]
34) Kaempferol 3- O-glucoside	Leaves	HPLC-DAD	[ 118]
35) Hyperoside	Leaves	HPLC-Q-TOF-MS/MS, HPLC-DAD	[ 81, 84]
36) (−)-Epigallocatechin	Leaves	HPLC-Q-TOF-MS/MS	[ 81]
37) Vicenin-2	Leaves	UHPLC-qTOF-MS, HPLC-Q-TOF-MS/MS	[ 81, 120]
38) Orientin	Leaves	HPLC-Q-TOF-MS/MS	[ 81]
39) Apigenin	Leaves	HPLC-Q-TOF-MS/MS, LC-MS, HPLC-DAD	[ 81, 82, 84]
40) Quercitrin	Leaves	LC-MS	[ 82]
41) Naringin	Leaves	LC-MS	[ 82]
42) Naringenin	Leaves	LC-MS	[ 82]
43) Luteolin	Leaves	LC-MS	[ 82]
44) Cirsilineol	Leaves	LC-MS	[ 82]
45) Acacetin	Leaves	LC-MS	[ 82]
46) Isoquercitrin	Leaves	HPLC-DAD, UHPLC-Q-Exactive-MS/MS	[ 123]

• ESIMS: Electrospray ionization mass spectrometry; HPLC: High performance liquid chromatography; HPLC-DAD: High performance liquid chromatography - diode array detector; HPLC-ESI-MS: High-performance liquid chromatography coupled to electrospray ionization tandem mass spectrometry; HPLC-Q-TOF-MS/MS: High performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry; LC-MS: Liquid chromatography - mass spectrometry; NMR: Nuclear magnetic resonance; UHPLC-qTOF-MS: Ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry; UHPLC-ESI-QTOF-MS/MS: Ultra-high pressure liquid chromatography accurate mass quadrupole time-of-flight mass spectrometry with electrospray ionization; UHPLC-Q-Exactive-MS/MS: Ultra--high performance liquid chromatography-quadrupole-electrostatic field Orbitrap mass spectrometry.

Figure 6.
Flavonoids with antimalarial potential.

Discussion

Despite the many reports of the use of M. oleifera in traditional medicine for the treatment of malaria in several countries and the evaluation of its extracts for their antimalarial potential in in vitro and in vivo experiments, this study identified some research gaps. Initially, it is important to note the absence of studies on the antimalarial activity of phytochemicals isolated from this plant. This fact makes it difficult, for example, to elucidate the mechanisms of action of compounds isolated from M. oleifera against malaria-causing parasites of the genus Plasmodium. Pan et al. [90] report the isolation of several antimalarial compounds from plants during the last decade, with many of these compounds showing significant in vitro activity against P. falciparum. These studies are essential for the discovery of new antimalarial drugs.

When evaluating the performance of an extract instead of isolated molecules, you have a phytocomplex, which can have synergistic compounds, as well as interfering compounds (PAINs). For the use of these extracts, standardization is recommended based on biomarkers that can be correlated with pharmacological activity, such as the flavonoids present in this species.

In addition to the metabolic composition, recent studies have pointed to a potential role for the microRNA of this species in the production of key molecules capable of justifying the bioactivity of this plant [91, 92]. In this perspective, studies of in vitro cell culture and callus of M. oleifera have already been carried out for the massive production of secondary metabolites and microRNA that present biological properties [93]. These studies bring perspectives for optimizing and obtaining pharmacologically active metabolites.

Furthermore, the present study did not find reports of randomized clinical trials of products obtained from M. oleifera that can be used in the treatment of malaria. Randomized clinical trials are needed before herbal remedies can be recommended on a large scale. As these studies are expensive and time-consuming, it is important to prioritize new drugs for clinical investigation according to existing data from sociological, ethnobotanical, pharmacological studies, and preliminary clinical observations [94]. Moreover, the observed in vitro studies were not carried out with resistant strains of Plasmodium, providing yet another gap in this study.

Therefore, considering the widespread use of M. oleifera by traditional communities for the treatment of malaria and the vast scientific evidence on its antimalarial potential in preclinical studies, it is important to carry out in vitro assays with resistant strains and clinical trials to ensure the effective and safe use of products obtained from this plant in humans.

Conclusion

Africans and Asians make large use of Moringa oleifera for the treatment of malaria. The leaves of this plant are the main parts used in the preparation of herbal medicines. The in vivo antimalarial activity of M. oleifera was confirmed through several studies using polar and nonpolar extracts, fractions obtained from the extracts, infusion, pellets, and oils obtained from this plant and tested in rodents infected by the following parasites of the Plasmodium genus: P. berghei, P. falciparum, P. yoelii, and P. chabaudi. Extracts obtained from M. oleifera showed no toxicity in preclinical tests. By using different chromatography and mass spectrometry methods, researchers identified a total of 46 flavonoids in M. oleifera leaves and seeds. Despite the scarcity of studies on the antimalarial potential of compounds isolated from M. oleifera, the positive effects against malaria-causing parasites observed in previous studies are likely to correlate with the flavonoids that occur in this species.

References

• 1. Possemiers H, Vandermosten L, Van den Steen PE. Etiology of lactic acidosis in malaria. PLoS Pathog. 2021 Jan 7;17(1):e1009122.
• 2. Chemison A, Ramstein G, Tompkins AM, Defrance D, Camus G, Charra M, Caminade C. Impact of an accelerated melting of Greenland on malaria distribution over Africa. Nat Commun. 2021 Jun;12:3971.
• 3. Gimenez AM, Marques RF, Regiart M, Bargieri DY. Diagnostic methods for non-falciparum malaria. Front Cell Infect Microbiol. 2021 Jun;11:681063.
• 4. Maqsood A, Farid MS, Khan MH, Grzegorzek M. Deep malaria parasite detection in thin blood smear microscopic images. Appl Sci. 2021 Mar;11(5):2284.
• 5. WHO - World Health Organization. World Malaria Report 2022. Geneva, World Health Organization, 2022. [cited 2023 Mars 09]. Available from: Available from: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022
  » https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022
• 6. Counihan NA, Modak JK, Koning-Ward TF. How malaria parasites acquire nutrients from their host. Front Cell Dev Biol. 2021 Mar;9:649184.
• 7. Laurens MB. RTS,S/AS01 vaccine (Mosquirix™): an overview. Hum Vaccin Immunother. 2020 Mar 3;16(3):480-9.
• 8. Al-Awadhi M, Ahmad S, Iqbal J. Current status and the epidemiology of malaria in the Middle East Region and beyond. Microorganisms. 2021 Feb;9:338.
• 9. Birkholtz LM, Alano P, Leroy D. Transmission-blocking drugs for malaria elimination. Trends Parasitol. 2022 May;38:390-403.
• 10. Erhirhie EO, Ikegbune C, Okeke AI, Onwuzuligbo CC, Madubuogwu NU, Chukwudulue UM, Okonkwo OB. Antimalarial herbal drugs: A review of their interactions with conventional antimalarial drugs. Clin Phytosci. 2021 Jan;7:4.
• 11. Kaur H, Mukhtar HM, Singh A, Mahajan A. Antiplasmodial medicinal plants: a literature review on efficacy, selectivity and phytochemistry of crude plant extracts. J Biol Act Prod Nat. 2018 Oct;8:272-94.
• 12. Dkhil MA, Al-Quraishy S, Al-Shaebi EM, Abdel-Gaber R, Thagfan FA, Qasem MA. Medicinal plants as a fight against murine blood-stage malaria. Saudi J Biol Sci. 2021 Mar;28(3):1723-38.
• 13. Fallatah O, Georges E. Apigenin-induced ABCC1-mediated efflux of glutathione from mature erythrocytes inhibits the proliferation of Plasmodium falciparum Int J Antimicrob Agents. 2017 Nov;50(5):673-77.
• 14. Amiri M, Nourian A, Khoshkam M, Ramazani A. Apigenin inhibits growth of the Plasmodium berghei and disrupts some metabolic pathways in mice. Phytother Res. 2018 Sep;32(9):1795-802.
• 15. Somsak V, Damkaew A, Onrak P. Antimalarial activity of kaempferol and its combination with chloroquine in Plasmodium berghei infection in mice. J Pathog. 2018 Dec 2;2018:3912090.
• 16. Ounjaijean S, Benjasak N, Sae-Lao S, Somsak V. Kaempferol addition increases the antimalarial activity of artesunate in experimental mice. J Trop Med. 2020 Jun;2020:6165928.
• 17. Ali AH, Sudi S, Shi-Jing N, Hassan WRM, Basir R, Agustar HK, Embi N, Sidek HM, Latip J. Dual anti-malarial and gsk3β-mediated cytokine-modulating activities of quercetin are requisite of its potential as a plant-derived therapeutic in malaria. Pharmaceuticals (Basel). 2021 Mar;14(3):248.
• 18. Bhatt D, Kumar S, Kumar P, Bisht S, Kumar A, Maurya AK, Pal A, Bawankule DU. Rutin ameliorates malaria pathogenesis by modulating inflammatory mechanism: an in vitro and in vivo study. Inflammopharmacology. 2022 Feb;30(1):159-71.
• 19. Dias MC, Pinto DCGA, Silva AMS. Plant Flavonoids: Chemical Characteristics and Biological Activity. Molecules. 2021 Sep;26(17):5377.
• 20. Penna-Coutinho J, Aguilar ACC, Krettri AU. Commercial drugs containing flavonoids are active in mice with malaria and in vitro against chloroquine-resistant Plasmodium falciparum Mem Inst Oswaldo Cruz. 2018 Dec;113:12.
• 21. Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V, Grau GE. Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost. 2009 Dec;102(6):1093-102.
• 22. Franklin BS, Ishizaka ST, Lamphier M, Gusovsky F, Hansen H, Rose J, Zheng W, Ataíde MA, Oliveira RB, Golenbock DT, Gazzinelli RT. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc Natl Acad Sci. 2011 Mar;108(9):3689-94.
• 23. Olson ME, Carlquist S. Stem and root anatomical correlations with life form diversity, ecology, and systematics in Moringa (Moringaceae). Bot J Linn Soc. 2001 Apr;135(4):315-48.
• 24. Padayachee B, Baijnath H. An overview of the medicinal importance of Moringaceae. J Med Plants Res. 2012 Dec;6:5831-9.
• 25. Kubitzki K. Moringaceae. In: Flowering Plants · Dicotyledons. The Families and Genera of Vascular Plants, 5. Kubitzki K, Bayer C, editors. Springer, Berlin, Heidelberg; 2003.
• 26. Rani NZA, Husain K, Kumolosasi E. Moringa Genus: A Review of Phytochemistry and Pharmacology. Front Pharmacol. 2018 Feb;9.
• 27. Mallenakuppe R, Homabalegowda H, Gouri MD, Basavaraju PS, Chandrashekharaiah UB. History, Taxonomy and Propagation of Moringa oleifera-A Review. SSR Inst Int J Life Sci. 2019 Apr;5:2322-7.
• 28. Ravi RSD, Nair BR, Siril EA. Morphological diversity, phenotypic and genotypic variance and heritability estimates in Moringa oleifera Lam.: a less used vegetable with substantial nutritional value. Genet Resour Crop Evol. 2021 Apr;68:3241-56.
• 29. Yang Y, Tian Y, He SL. Characterization of the complete chloroplast genome of Moringa oleifera Lam. (Moringaceae), an important edible species in India. Mitochondrial DNA B: Resour. 2019 May;4:1913-5.
• 30. Granella SJ, Bechlin TR, Christ D, Coelho SRM, Paz CHO. An approach to recent applications of Moringa oleifera in the agricultural and biofuel industries. S Afr J Bot. 2021 Mar;137:110-6.
• 31. Lagnika L, Djehoue R, Yedomonhan H, Sanni A. Ethnobotanical survey of medicinal plants used in malaria management in South Benin. J Med Plant Res. 2016 Nov;10:748-56.
• 32. Shah A, Rahim S. Ethnomedicinal uses of plants for the treatment of malaria in Soon Valley, Khushab, Pakistan. J Ethnopharmacol. 2017 Mar;200:84-106.
• 33. Suleman S, Tufa TB, Kebebe D, Belew S, Mekonnen Y, Gashe F, Musa S, Wynendaele E, Duchateau L, Spiegeleer B. Treatment of malaria and related symptoms using traditional herbal medicine in Ethiopia. J Ethnopharmacol. 2018 Mar;213:262-79.
• 34. Oyeyemi IT, Akinseye KM, Adebayo SS, Oyetunji MT, Oyeyemi OT. Ethnobotanical survey of the plants used for the management of malaria in Ondo State, Nigeria. S Afr J Bot. 2019 Aug;124:391-401.
• 35. Taek MM, Banilodu L, Neonbasu G, Watu YV, EW BP, Agil M. Ethnomedicine of Tetun ethnic people in West Timor Indonesia: Philosophy and practice in the treatment of malaria. Integr Med Res. 2019 Sep;8(3):139-44.
• 36. Malinga GM, Baana K, Rutaro K, Opoke R, Atube F, Opika-Opoka H, Oryema C. An ethnobotanical study of plants used for the treatment of malaria in Budondo sub-county, Eastern Uganda. Ethnobot Res Appl. 2020 Jan;19:1-15.
• 37. Oladeji OS, Oluyori AP, Bankole DT, Afolabi TY. Natural products as sources of antimalarial drugs: ethnobotanical and ethnopharmacological studies. Scientifica. 2020 May;2020:7076139.
• 38. Saikia S, Begum RA, Buragohain A. Comprehensive list of anti-malarial plants used by different communities of Assam and Arunachal Pradesh, India. Int J Mosq Res. 2021 Feb;8:63-9.
• 39. Mulisa E, Girma B, Tesema S, Yohannes M, Zemene E, Amelo W. Evaluation of in vivo antimalarial activities of leaves of Moringa oleifera against Plasmodium berghei in mice. Jundishapur J Nat Pharm Prod. 2018 Feb;13:e60426.
• 40. Daskum AM, Godly C, Qadeer MA. Antiplasmodial activities of crude Moringa oleifera leaves extracts on chloroquine sensitive Plasmodium falciparum (3D7). Bayero J Pure Appl Sci. 2019 Nov;12(1):315-20.
• 41. Olaniran O, Adetuyi FC, Omoya FO, Odediran SA, Hassan-olajokun RE, Awoyeni EA, Odetoyin BW, Adesina A, Awe A, Bejide RA, Odujoko O, Akinyemi LO, Oyetoke OO, Afolayan DO. Antiplasmodial, antipyretic, haematological and histological effects of the leaf extracts of Moringa oleifera in Plasmodium berghei berghei infected mice. J Adv Med Med Res. 2019 Apr;29:1-13.
• 42. Obediah GA, Obi NC. Anti-plasmodial effect of Moringa oleifera seeds in Plasmodium berghei infected albino rats. Biochem Pharmacol. 2020 Jan;9(1):2167-501.
• 43. Pilotos J, Ibrahim KA, Mowa CN, Opata MM. Moringa oleifera treatment increases Tbet expression in CD4+ T cells and remediates immune defects of malnutrition in Plasmodium chabaudi-infected mice. Malar J. 2020 Feb;19(1):62.
• 44. Abdulahi SK, Dada EO, Adebayo RO. Histopathological effects of seed oil of Moringa oleifera Lam. on albino mice infected with Plasmodium berghei (NK65). Adv J Grad Res. 2022 Dec;11:71-9.
• 45. Stohs SJ, Hartman MJ. Review of the safety and efficacy of Moringa oleifera Phytother Res. 2015 Mar;29(6):796-804.
• 46. Olson ME. Combining data from DNA sequences and morphology for a phylogeny of Moringaceae (Brassicales). Syst Bot. 2002 Jan;27(1):55-73.
• 47. Velázquez-Zavala M, Peón-Escalante IE, Zepeda-Bautista R, Jiménez-Arellanes MA. Moringa ( Moringa oleifera Lam.): potential uses in agriculture, industry and medicine. Rev Chapingo Ser Hortic. 2016 May-Aug;22:95-116.
• 48. Degarege A, Fennie K, Degarege D, Chennupati S, Madhivanan P. Improving socioeconomic status may reduce the burden of malaria in sub Saharan Africa: A systematic review and meta-analysis. PloS One. 2019 Jan;14(1):e0211205.
• 49. Tangena JAA, Hendriks CM, Devine M, Tammaro M, Trett AE, Williams I, DePina AJ, Sisay A, Herizo R, Kafy HT, Chizema E, Were A, Rozier J, Coleman M, Moyes CL. Indoor residual spraying for malaria control in sub-Saharan Africa 1997 to 2017: an adjusted retrospective analysis. Malar J. 2020 Apr 10;19(1):150.
• 50. Okumu F, Gyapong M, Casamitjana N, Castro MC, Itoe MA, Okonofua F, Tanner M. What Africa can do to accelerate and sustain progress against malaria. PLOS Glob Public Health. 2022 Jun;2(6):e0000262.
• 51. Adekunle MF. Indigenous uses of plant leaves to treat malaria fever at Omo Forest reserve (OFR) Ogun state, Nigeria. Ethiop J Environ Stud Manag. 2008 Sep;1(1):31-5.
• 52. Dube FF, Tadesse K, Birgersson G, Seyoum E, Tekie H, Ignell R, Hill SR. Fresh, dried or smoked? Repellent properties of volatiles emitted from ethnomedicinal plant leaves against malaria and yellow fever vectors in Ethiopia. Malar J. 2011 Dec 19;10:375.
• 53. Alebie G, Urga B, Worku A. Systematic review on traditional medicinal plants used for the treatment of malaria in Ethiopia: trends and perspectives. Malar J. 2017 Aug 1;16:307.
• 54. Popoola JO, Obembe OO. Local knowledge, use pattern and geographical distribution of Moringa oleifera Lam. (Moringaceae) in Nigeria. J Ethnopharmacol. 2013 Nov;150(2):682-91.
• 55. Singh S, Singh R. Herbal medicinal treatment of Malaria in Aliero local government area, Kebbi, Nigeria. J Med Plants Stud. 2014 Feb;2:117-26.
• 56. Ishola IO, Oreagba IA, Adeneye AA, Adirije C, Oshikoya KA, Ogunleye OO. Ethnopharmacological survey of herbal treatment of malaria in Lagos, Southwest Nigeria. J Herb Med. 2014 Dec;4(4):224-34.
• 57. Iyamah PC, Idu M. Ethnomedicinal survey of plants used in the treatment of malaria in Southern Nigeria. J Ethnopharmacol. 2015 Sep 15;173:287-302.
• 58. Igberaese PO, Ogbole OO. Ethnobotanical survey of plants used in the treatment of typhoid and its complication(s) in Esan North East local government area, Uromi, Edo state. Niger J Pharm Res. 2018 Jan;14(2):175-88.
• 59. Gani AM, Kolawole OS, Dahiru M, Isyaka MS. Management of Malaria: An Account by the Indigenous People of Kashere and Its Environs, Gombe State, Nigeria. Egypt Acad J Biolog Sci. 2019 Dec;10:27-40.
• 60. Cole AT, Kayode J. Urban forestry and ethno medicine: The meeting point in malaria control in Ijesa Region, Nigeria. Bp Int Res Exact Sci. 2020 Jul;2:291-97.
• 61. Zakawa NN, Timon D, Yusuf CS, Oyebanji EO, Batta K, Jalani RT. Ethno-botanical survey and phytochemical analysis of Moringa oleifera in mubi local government of Adamawa state. J Med Plants Stud. 2020 Feb;8:107-11.
• 62. Tabuti JR. Herbal medicines used in the treatment of malaria in Budiope county, Uganda. J Ethnopharmacol. 2008 Feb 28;116(1):33-42.
• 63. Ajayi CO, Elujoba AA, Kasali FM, Tenywa MG, Okella H, Weisheit A, Tolo CU, Ogwang PE. A review for selecting medicinal plants commonly used for malaria in Uganda. Afr J Pharm Pharmacol. 2020 Oct;14(9):347-61.
• 64. Yetein MH, Houessou LG, Lougbégnon TO, Teka O, Tente B. Ethnobotanical study of medicinal plants used for the treatment of malaria in plateau of Allada, Benin (West Africa). J Ethnopharmacol. 2013 Mar 7;146(1):154-63.
• 65. Agoyi EE, Assogbadjo AE, Gouwakinnou G, Okou FA, Sinsin B. Ethnobotanical Assessment of Moringa oleifera Lam. in Southern Benin (West Africa). Ethnobot Res Appl. 2014 Nov;12(2014):551-60.
• 66. Yaw VB, Osafo AS, Ben AG. Ethnobotanical survey of plants used in the treatment of malaria in the sekyere central district of ashanti region of Ghana. Int J Novel Res Life Sci. 2008 Nov-Dec;2:17-25.
• 67. Asase A, Akwetey GA, Achel DG. Ethnopharmacological use of herbal remedies for the treatment of malaria in the Dangme West District of Ghana. J Ethnopharmacol. 2010 Jun;129(3):367-76.
• 68. Komlaga G, Agyare C, Dickson RA, Mensah MLK, Annan K, Loiseau PM, Champy P. Medicinal plants and finished marketed herbal products used in the treatment of malaria in the Ashanti region, Ghana. J Ethnopharmacol. 2015 Aug 22;172:333-46.
• 69. Orman E, Addo P, Ofori MF, Reimmel KA. Investigating the in-vivo antiplasmodial properties of aqueous extract of Moringa oleifera Lam (Moringaceae) leaves. Br J Pharm Res. 2015 Feb;5(6):419-30.
• 70. Dondee K, Borkaew P, Klubsri C, Bootprom P, Saiphet B, Somsak V. The protective effect of Moringa oleifera leaf extract on liver damage in mice infected with Plasmodium berghei ANKA. J Coast Life Med. 2016 Sep;4:742-6.
• 71. Somsak V, Borkaew P, Klubsri C, Dondee K, Bootprom P, Saiphet B. Antimalarial properties of aqueous crude extracts of Gynostemma pentaphyllum and Moringa oleifera leaves in combination with artesunate in Plasmodium berghei-infected mice. J Trop Med. 2016 Oct;2016:8031392.
• 72. Nakinchat S, Somsak V. A pilot study on antimalarial effects of Moringa oleifera leaf extract in Plasmodium berghei infection in mice. Walailak J Sci Tech. 2017 Nov;15(2):151-6.
• 73. Köhler I, Jenett-Siems K, Siems K, Hernández MA, Ibarra RA, Berendsohn WG, Bienzle U, Eich E. In vitro antiplasmodial investigation of medicinal plants from El Salvador. Z Naturforsch C J Biosci. 2002 Mar-Apr;57(3-4):277-81.
• 74. Ogundapo SS, Ezeanyika LUS, Uzoegwu PN, Soniran OT, Okoro DO, Okoronkwo I, Okoro JA, Okochi PC, Chukwunwike OO. Evaluation of Moringa oleifera as anti-plasmodial agents in the control of malaria. Niger J Parasitol. 2015 Mar;36(1):22-7.
• 75. Dondee K, Bootprom P, Saiphet B, Borkaew P, Klubsri C, Somsak V. Antimalarial activities of Moringa oleifera leaf extract against Plasmodium berghei ANKA infection in ICR mice. Int J Innov Res Med Sci. 2016 Jul;1:194-201.
• 76. Olasehinde GI, Ayanda OI, Egwari LO, Ajayi AA, Awofeso T. In vivo antiplasmodial activity of crude ethanolic and N-hexane extracts of Moringa oleifera leaves. Int J Agri Bio. 2016 18:906-10.
• 77. Shrivastava M, Prasad A, Kumar D. Evaluation of anti malarial effect Moringa oleifera (Lam) in Plasmodium yoelii infected mice. Indian J Pharm Sci. 2021 Sep;83(6):1221-8.
• 78. John CC, Kutamba E, Mugarura K, Opoka RO. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti-Infect Ther. 2010 Sep;8(9):997-1008.
• 79. Gomes AP, Vitorino RR, Costa ADP, Mendonça EGD, Oliveira MGDA, Siqueira-Batista R. Severe Plasmodium falciparum malaria. Rev Bras Ter Intensiva. 2011 Sep;23:358-69.
• 80. Wahlgren M, Goel S, Akhouri RR. Variant surface antigens of Plasmodium falciparum and their roles in severe malaria. Nat Rev Microbiol. 2017 Aug;15(8):479-91.
• 81. Wu L, Li L, Chen S, Wang L, Lin X. Deep eutectic solvent-based ultrasonic-assisted extraction of phenolic compounds from Moringa oleifera L. leaves: Optimization, comparison and antioxidant activity. Sep Purif Technol. 2020 Sep 15;247:117014.
• 82. Bennour N, Mighri H, Bouhamda T, Mabrouk M, Apohan E, Yesilada O, Küçükbay H, Akrout A. Moringa oleifera leaves: could solvent and extraction method affect phenolic composition and bioactivities? Prep Biochem Biotechnol. 2021 Mar;51(10):1018-25.
• 83. Hamed YS, Abdin M, Rayan AM, Akhtar HMS, Zeng X. Synergistic inhibition of isolated flavonoids from Moringa oleifera leaf on α-glucosidase activity. LWT. 2021 Apr;141:111081.
• 84. Lin X, Wu L, Wang X, Yao L, Wang L. Ultrasonic-assisted extraction for flavonoid compounds content and antioxidant activities of India Moringa oleifera L. leaves: Simultaneous optimization, HPLC characterization and comparison with other methods. J Appl Res Med Aromat Plants. 2021 Feb;20:100284.
• 85. Tofiq SA, Azeez HA, Othman HH. Wound healing activities of Moringa oleifera leaves extract cultivated in Kurdistan region-Iraq. Jordan J Biol Sci. 2021 Dec;14:637-45.
• 86. Lim SS, Kim HS, Lee DU. In vitro antimalarial activity of flavonoids and chalcones. Bull Korean Chem Soc. 2007 Dec;28(12):2495-7.
• 87. Fotie J. The antiprotozoan potential of flavonoids. Pharmacogn Rev. 2008 Jan;2(3):6-19.
• 88. Rudrapal M, Chetia D. Plant flavonoids as potential source of future antimalarial leads. Sys Rev Pharm. 2017 Jan-Dec;8:13-8.
• 89. Boniface PK, Ferreira EI. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue. Phytother Res. 2019 Aug 23;33(10):2473-517.
• 90. Pan WH, Xu XY, Shi N, Tsang SW, Zhang HJ. Antimalarial activity of plant metabolites. Int J Mol Sci. 2018 May 6;19(5):1382.
• 91. Förster N, Ulrichs C, Schreiner M, Arndt N, Schmidt R, Mewis I. Ecotype variability in growth and secondary metabolite profile in Moringa oleifera: impact of sulfur and water availability. J Agric Food Chem. 2015 Mar 25;63(11):2852-61.
• 92. Gismondi A, Di Marco G, Camoni L, Montesano C, Braglia R, Marra M, Canini A. MicroRNA Expression Profiles in Moringa oleifera Lam. Seedlings at Different Growth Conditions. J Plant Growth Regul. 2022 Jun 8.
• 93. Zanella L, Gismondi A, Di Marco G, Braglia R, Scuderi F, Redi EL, Galgani A, Canini A. Induction of antioxidant metabolites in Moringa oleifera callus by abiotic stresses. J Nat Prod. 2019 Aug;82(9):2379-86.
• 94. Willcox ML, Bodeker G. Traditional herbal medicines for malaria. BMJ. 2004 Nov 13;329(7475):1156-9.
• 95. Koudouvo K, Karou DS, Kokou K, Essien K, Aklikokou K, Glitho IA, Simpore J, Sonogo R, Souza CD, Gbeassor M. An ethnobotanical study of antimalarial plants in Togo Maritime Region. J Ethnopharmacol. 2011 Mar 8;134(1):183-90.
• 96. Dossou-Yovo HO, Vodouhè FG. Ethnobotanical survey of mangrove plant species used as medicine from ouidah to grand-popo districts, southern Benin. Am J Ethnomed. 2017 Nov;4:1-6.
• 97. Nda-Umar UI, Gbate M, Umar AN, Mann A. Ethnobotanical study of medicinal plants used for the treatment of malaria in Nupeland, north central Nigeria. Global J Res Med Plants Indigen Med. 2014 Apr;3:112-26.
• 98. Nondo RSO, Zofou D, Moshi MJ, Erasto P, Wanji S, Ngemenya MN, Titanji VPK, Kidukuli AW, Masimba PJ. Ethnobotanical survey and in vitro antiplasmodial activity of medicinal plants used to treat malaria in Kagera and Lindi regions, Tanzania. J Med Plant Res. 2015 Feb;9:179-92.
• 99. Anywar G, Van’t Klooster CI, Byamukama R, Willcox M, Nalumansi PA, Jong JD, Rwaburindori P, Kiremire BT. Medicinal plants used in the treatment and prevention of malaria in Cegere Sub-County, Northern Uganda. Ethnobot Res Appl. 2016 Jan;14(2015):505-16.
• 100. Olivier TT, Francis NT, Armel S, Jackson KJ, Justin N. Ethnobotanic survey of medicinal plants used for malaria therapy in western Cameroon. J Med Plants Stud. 2016 Apr;248(43):248-58.
• 101. Mutwiwa C, Rotich B, Kauti M, Rithaa J. Ethnobotanical survey of medicinal plants in Mwala sub-county, Machakos County, Kenya. J Dis Med Plants, 2018 Aug;4(4):110-9.
• 102. Odoh UE, Uzor PF, Eze CL, Akunne TC, Onyegbulam CM, Osadebe PO. Medicinal plants used by the people of Nsukka Local Government Area, south-eastern Nigeria for the treatment of malaria: An ethnobotanical survey. J Ethnopharmacol. 2018 May;218:1-15.
• 103. Yaovi-Gameli A, Koffi K, Komlavi E, Amegnona A, Koffi T, Messanvi G. An Ethnobotanical survey of medicinal plants used in the preparation of “Atikédi”: Local alcoholic beverages commonly consumed in Lomé Togo. Eur Sci J. 2018 Nov;14:1-16.
• 104. Mukhtar Y, Adam A, Abdulkadir A, Yakudima I, Galalain A. Ethno botanical survey of medicinal flora used for the treatment of malaria in Madobi Town, Kano State-Nigeria. Iconic Res Eng J. 2019 Aug;3:400-9.
• 105. Okello D, Kang Y. Exploring antimalarial herbal plants across communities in Uganda based on electronic data. Evid Based Complement Altern Med. 2019 Sep 15;2019:3057180.
• 106. Dogara MA, Umar UU, Usman M, Sunusi N, Ladan S, Lema AA. Survey of medicinal plants used for the treatment of malaria in Kaduna state, Nigeria. Katsina J Nat Appl Sci. 2021 Sep;10:14-24.
• 107. Muchaia AJ, Nanvonamuquitxo SJA. Levantamento etnobotânico de plantas medicinais utilizadas pela comunidade de Nacuale, no Parque Nacional das Quirimbas, Moçambique. Nativa. 2021 Dec;9:605-11.
• 108. Zakariya AM, Adamu A, Nuhu A, Kiri IZ. Assessment of indigenous knowledge on medicinal plants used in the management of malaria in Kafin Hausa, north-western Nigeria. Ethnobot Res Appl. 2021 Jul;22(2021):1-18.
• 109. Kroa E, Soumahoro A, Kouamé BY, Tiembre I, Yobouet MK. Antimalarial and antianemic medicinal plants used by traditional medicine practitioners and the populations of the Korhogo 1 health district (Poro Region, Ivory Coast). GSC Biol Pharm Sci. 2022 Apr;19:154-71.
• 110. Olasehinde GI, Ayanda OI, Ajayi AA, Nwabueze AP. In-vivo antiplasmodial activity of crude n-hexane and ethanolic extracts of Moringa oleifera (Lam.) seeds on Plasmodium berghei Int J Med Plant Res. 2012 Oct;1:50-4.
• 111. Ogundapo SS, Ezeanyika LU, Uzoegwu PN, Soniran OT. Potentiation of chloroquine by antiplasmodial fraction of Moringa oleifera leaves in drug resistant Plasmodium berghei infection. Invest Med Chem Pharmacol. 2019 2:22.
• 112. Ogundapo SS, Soniran OT, Suleiman JB, Chigozie K, Ngobidi NAO, Olugbue VU, Chukwunwike OO, Olatunji ID. CYP450-mediated metabolites of aqueous leaves extract of Moringa oleifera inhibits absorption of chloroquine in Plasmodium yoeli yoeli infection. Invest Med Chem Pharmacol. 2019;2:23.
• 113. Ajayi CO, Elujoba AA, Okella H, Oloro J, Raymond A, Weisheit A, Tolo CU, Ogwang PE. In vivo antimalarial activities of five Ugandan medicinal plants on Plasmodium berghei in mice. European J Med Plants. 2020 Aug;31:1-13.
• 114. Singh RG, Negi PS, Radha C. Phenolic composition, antioxidant and antimicrobial activities of free and bound phenolic extracts of Moringa oleifera seed flour. J Funct Foods. 2013 Oct;5:1883-91.
• 115. Shervington LA, Li BS, Shervington AA, Alpan N, Patel R, Muttakin U, Mulla E. A comparative HPLC analysis of myricetin, quercetin and kaempferol flavonoids isolated from Gambian and Indian Moringa oleifera leaves. Int J Chem. 2018 Nov;10:28-37.
• 116. Oldoni TLC, Merlin N, Karling M, Carpes ST, Alencar SM, Morales RGF, Silva EA, Pilau EJ. Bioguided extraction of phenolic compounds and UHPLC-ESI-Q-TOF-MS/MS characterization of extracts of Moringa oleifera leaves collected in Brazil. Food Res Int. 2019 Nov;125:108647.
• 117. Rani NZA, Kumolosasi E, Jasamai M, Jamal JA, Lam KW, Husain K. In vitro anti-allergic activity of Moringa oleifera Lam. extracts and their isolated compounds. BMC Complement Altern Med. 2019 Dec;19:361.
• 118. Pollini L, Tringaniello C, Ianni F, Blasi F, Manes J, Cossignani L. Impact of ultrasound extraction parameters on the antioxidant properties of Moringa oleifera leaves. Antioxidants. 2020 Mar;9:277.
• 119. Vongsak B, Sithisarn P, Mangmool S, Thongpraditchote S, Wongkrajang Y, Gritsanapan W. Maximizing total phenolics, total flavonoids contents and antioxidant activity of Moringa oleifera leaf extract by the appropriate extraction method. Ind Crops Prod. 2013 Jan;44:566-71.
• 120. Makita C, Chimuka L, Steenkamp P, Cukrowska E, Madala E. Comparative analyses of flavonoid content in Moringa oleifera and Moringa ovalifolia with the aid of UHPLC-qTOF-MS fingerprinting. S Afr J Bot. 2016 Jul;105:116-22.
• 121. Premi M, Sharma HK. Effect of extraction conditions on the bioactive compounds from Moringa oleifera (PKM 1) seeds and their identification using LC-MS. J Food Meas Charact. 2017 Mar;11:213-25.
• 122. Hamed YS, Abdin M, Akhtar HMS, Chen D, Wan P, Chen G, Zeng X. Extraction, purification by macrospores resin and in vitro antioxidant activity of flavonoids from Moringa oliefera leaves. S Afr J Bot. 2019 Aug;124:270-9.
• 123. Gao Q, Wei Z, Liu Y, Wang F, Zhang S, Serrano C, Li L, Sun B. Characterization, Large-Scale HSCCC Separation and Neuroprotective Effects of Polyphenols from Moringa oleifera Leaves. Molecules. 2022 Jan 20;27(3):678.

• Availability of data and materials

  Not applicable.

• Funding

  The present study was supported by National Council for Scientific and Technological Development (CNPq), Brazil.

• Ethics approval

  Not applicable.

• Consent for publication

  Not applicable

Supplementary material

The following online material is available for this article:

Additional file 1. Characterization of the articles selected in the databases and included in the review (n = 72).

Publication Dates

• Publication in this collection
  26 May 2023
• Date of issue
  2023

History

• Received
  07 Nov 2022
• Accepted
  27 Apr 2023